Our Team

Interim Scientific Director: Professor Andrew Forbes
Professor Andrew Forbes obtained his PhD from Cornell University, USA, in 1990 and has been at Monash University since 1992. His roles include teaching, research and consulting, and he is Head of the Division of Research Methodology within the School of Public Health and Preventive Medicine. His areas of research interest are methods for cluster randomised trials, causal inference techniques applied to epidemiological and clinical research, and interrupted time series.
Senior Biostatistician: Dr Eldho Paul
Eldho Paul has been working as a Research Fellow in the School of Public Health and Preventive Medicine since 2008. He has a background in biostatistics and works as a consultant statistician for The Alfred Hospital.
Senior Biostatistician: Associate Professor Arul Earnest
Arul Earnest is an Associate Professor with the School of Public Health and Preventive Medicine. His current research interests are in Bayesian spatio-temporal models, time-series analysis, longitudinal data analysis and Registry Science.
Senior Biostatistician: Dr Lucy Busija
Lucy has an undergraduate background in psychology, with postgraduate qualifications in applied statistics (Master of Science in Applied Statistics, Swinburne University) and epidemiology (PhD, The University of Melbourne). She specialises in the application of advanced statistical methods to the study of risks, burden, and outcomes of chronic ill health. She also has a special interest and expertise in the design and analysis of randomised controlled trials (RCT) and is currently a PI statistician on a number of ongoing trials. Her other areas of interest are in latent variable modelling, including structural equation modelling, item response theory, and latent class analysis, especially the application of these methods in the field of psychometrics.
Senior Biostatistician: Dr Catherine Martin
Catherine has worked as a biostatistician in the School of Public Health and Preventive Medicine since 2015. She has a Masters in Biostatistics and a PhD in Medicine. She has been involved with, and provided biostatistical consultations to, a wide range of research areas in the medical sciences and has experience in study design, data management, safety monitoring and analysis of both RCTs and longitudinal cohort studies. Her primary role is to assist faculty researchers with the design and analysis of clinical studies.

Affiliated Consultants

Professor Rory Wolfe has been a biostatistician at Monash University since 2000 and contributes to a wide range of epidemiological, public health and clinical research studies. He has published over 300 peer-reviewed articles. Rory obtained his PhD in applied statistics from Southampton University (UK), subsequently did postdoctoral research in statistical methodology for longitudinal studies, and maintains methodological interests across a number of areas including risk prediction models and clinical trials.
Professor Stephane Heritier is a biostatistician at Monash University. He obtained his PhD in statistics at the University of Geneva (Switzerland). Stephane has been involved in the design and analysis of large-scale studies, mainly in cardiovascular and renal diseases, neurological and mental health, critical care and injury prevention. His research interests include adaptive designs, cluster randomised trials, survival analysis and robust statistics.
Associate Professor Jessica Kasza received her PhD in Statistics from the University of Adelaide in 2010, and has been a member of the Biostatistics Unit since 2013. She has particular interests in multiple-period cluster randomised trials, healthcare provider comparison, and causal inference.
Dr Kim Jachno has a Master in Biostatistics and received her PhD from Monash University in 2021. She has been involved with, and provided biostatistical consultations in a wide range of research areas – study design, data management, monitoring and analysis of both RCTs and longitudinal cohort studies. Prior to working in the biostatistical field, Kim had over a decade of experience working as a Research Scientist in pharmaceutical companies and the CSIRO on a range of drug design and preclinical validation projects.